Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer

Colin A Espie, Leanne Fleming, James Cassidy, Leslie Samuel, Lynne M Taylor, Craig A White, Neil J Douglas, Heather M Engleman, Heidi-Louise Kelly, James Paul

Research output: Contribution to journalArticle

Abstract

PURPOSE: Persistent insomnia is a common complaint in cancer survivors, but is seldom satisfactorily addressed. The adaptation to cancer care of a validated, cost-effective intervention may offer a practicable solution. The aim of this study was to investigate the clinical effectiveness of protocol-driven cognitive behavior therapy (CBT) for insomnia, delivered by oncology nurses.

PATIENTS AND METHODS: Randomized, controlled, pragmatic, two-center trial of CBT versus treatment as usual (TAU) in 150 patients (103 females; mean age, 61 years.) who had completed active therapy for breast, prostate, colorectal, or gynecological cancer. The study conformed to CONSORT guidelines. Primary outcomes were sleep diary measures at baseline, post-treatment, and 6-month follow-up. Actigraphic sleep, health-related quality of life (QOL), psychopathology, and fatigue were secondary measures. CBT comprised five, small group sessions across consecutive weeks, after a manualized protocol. TAU represented normal clinical practice; the appropriate control for a clinical effectiveness study.

RESULTS: CBT was associated with mean reductions in wakefulness of 55 minutes per night compared with no change in TAU. These outcomes were sustained 6 months after treatment. Standardized relative effect sizes were large for complaints of difficulty initiating sleep, waking from sleep during the night, and for sleep efficiency (percentage of time in bed spent asleep). CBT was associated with moderate to large effect sizes for five of seven QOL outcomes, including significant reduction in daytime fatigue. There was no significant interaction effect between any of these outcomes and baseline demographic, clinical, or sleep characteristics.

CONCLUSION: CBT for insomnia may be both clinically effective and feasible to deliver in real world practice.

Original languageEnglish
Pages (from-to)4651-4658
Number of pages8
JournalJournal of Clinical Oncology
Volume26
Issue number28
DOIs
Publication statusPublished - 1 Oct 2008
Externally publishedYes

Fingerprint

Sleep Initiation and Maintenance Disorders
Cognitive Therapy
Sleep
Randomized Controlled Trials
Neoplasms
Fatigue
Therapeutics
Quality of Life
Wakefulness
Clinical Protocols
Psychopathology
Survivors
Prostate
Breast
Nurses
Demography
Guidelines
Costs and Cost Analysis

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Cognitive Therapy
  • Female
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Neoplasms
  • Psychometrics
  • Quality of Life
  • Sleep Initiation and Maintenance Disorders
  • Treatment Outcome

Cite this

Espie, Colin A ; Fleming, Leanne ; Cassidy, James ; Samuel, Leslie ; Taylor, Lynne M ; White, Craig A ; Douglas, Neil J ; Engleman, Heather M ; Kelly, Heidi-Louise ; Paul, James. / Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. In: Journal of Clinical Oncology. 2008 ; Vol. 26, No. 28. pp. 4651-4658.
@article{6ca5b94c6a724771a737c9700680b5a4,
title = "Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer",
abstract = "PURPOSE: Persistent insomnia is a common complaint in cancer survivors, but is seldom satisfactorily addressed. The adaptation to cancer care of a validated, cost-effective intervention may offer a practicable solution. The aim of this study was to investigate the clinical effectiveness of protocol-driven cognitive behavior therapy (CBT) for insomnia, delivered by oncology nurses.PATIENTS AND METHODS: Randomized, controlled, pragmatic, two-center trial of CBT versus treatment as usual (TAU) in 150 patients (103 females; mean age, 61 years.) who had completed active therapy for breast, prostate, colorectal, or gynecological cancer. The study conformed to CONSORT guidelines. Primary outcomes were sleep diary measures at baseline, post-treatment, and 6-month follow-up. Actigraphic sleep, health-related quality of life (QOL), psychopathology, and fatigue were secondary measures. CBT comprised five, small group sessions across consecutive weeks, after a manualized protocol. TAU represented normal clinical practice; the appropriate control for a clinical effectiveness study.RESULTS: CBT was associated with mean reductions in wakefulness of 55 minutes per night compared with no change in TAU. These outcomes were sustained 6 months after treatment. Standardized relative effect sizes were large for complaints of difficulty initiating sleep, waking from sleep during the night, and for sleep efficiency (percentage of time in bed spent asleep). CBT was associated with moderate to large effect sizes for five of seven QOL outcomes, including significant reduction in daytime fatigue. There was no significant interaction effect between any of these outcomes and baseline demographic, clinical, or sleep characteristics.CONCLUSION: CBT for insomnia may be both clinically effective and feasible to deliver in real world practice.",
keywords = "Adult, Aged, Aged, 80 and over, Cognitive Therapy, Female, Humans, Linear Models, Male, Middle Aged, Neoplasms, Psychometrics, Quality of Life, Sleep Initiation and Maintenance Disorders, Treatment Outcome",
author = "Espie, {Colin A} and Leanne Fleming and James Cassidy and Leslie Samuel and Taylor, {Lynne M} and White, {Craig A} and Douglas, {Neil J} and Engleman, {Heather M} and Heidi-Louise Kelly and James Paul",
note = "Unable to verify author affiliations. (SM / NH)",
year = "2008",
month = "10",
day = "1",
doi = "10.1200/JCO.2007.13.9006",
language = "English",
volume = "26",
pages = "4651--4658",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "28",

}

Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. / Espie, Colin A; Fleming, Leanne; Cassidy, James; Samuel, Leslie; Taylor, Lynne M; White, Craig A; Douglas, Neil J; Engleman, Heather M; Kelly, Heidi-Louise; Paul, James.

In: Journal of Clinical Oncology, Vol. 26, No. 28, 01.10.2008, p. 4651-4658.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer

AU - Espie, Colin A

AU - Fleming, Leanne

AU - Cassidy, James

AU - Samuel, Leslie

AU - Taylor, Lynne M

AU - White, Craig A

AU - Douglas, Neil J

AU - Engleman, Heather M

AU - Kelly, Heidi-Louise

AU - Paul, James

N1 - Unable to verify author affiliations. (SM / NH)

PY - 2008/10/1

Y1 - 2008/10/1

N2 - PURPOSE: Persistent insomnia is a common complaint in cancer survivors, but is seldom satisfactorily addressed. The adaptation to cancer care of a validated, cost-effective intervention may offer a practicable solution. The aim of this study was to investigate the clinical effectiveness of protocol-driven cognitive behavior therapy (CBT) for insomnia, delivered by oncology nurses.PATIENTS AND METHODS: Randomized, controlled, pragmatic, two-center trial of CBT versus treatment as usual (TAU) in 150 patients (103 females; mean age, 61 years.) who had completed active therapy for breast, prostate, colorectal, or gynecological cancer. The study conformed to CONSORT guidelines. Primary outcomes were sleep diary measures at baseline, post-treatment, and 6-month follow-up. Actigraphic sleep, health-related quality of life (QOL), psychopathology, and fatigue were secondary measures. CBT comprised five, small group sessions across consecutive weeks, after a manualized protocol. TAU represented normal clinical practice; the appropriate control for a clinical effectiveness study.RESULTS: CBT was associated with mean reductions in wakefulness of 55 minutes per night compared with no change in TAU. These outcomes were sustained 6 months after treatment. Standardized relative effect sizes were large for complaints of difficulty initiating sleep, waking from sleep during the night, and for sleep efficiency (percentage of time in bed spent asleep). CBT was associated with moderate to large effect sizes for five of seven QOL outcomes, including significant reduction in daytime fatigue. There was no significant interaction effect between any of these outcomes and baseline demographic, clinical, or sleep characteristics.CONCLUSION: CBT for insomnia may be both clinically effective and feasible to deliver in real world practice.

AB - PURPOSE: Persistent insomnia is a common complaint in cancer survivors, but is seldom satisfactorily addressed. The adaptation to cancer care of a validated, cost-effective intervention may offer a practicable solution. The aim of this study was to investigate the clinical effectiveness of protocol-driven cognitive behavior therapy (CBT) for insomnia, delivered by oncology nurses.PATIENTS AND METHODS: Randomized, controlled, pragmatic, two-center trial of CBT versus treatment as usual (TAU) in 150 patients (103 females; mean age, 61 years.) who had completed active therapy for breast, prostate, colorectal, or gynecological cancer. The study conformed to CONSORT guidelines. Primary outcomes were sleep diary measures at baseline, post-treatment, and 6-month follow-up. Actigraphic sleep, health-related quality of life (QOL), psychopathology, and fatigue were secondary measures. CBT comprised five, small group sessions across consecutive weeks, after a manualized protocol. TAU represented normal clinical practice; the appropriate control for a clinical effectiveness study.RESULTS: CBT was associated with mean reductions in wakefulness of 55 minutes per night compared with no change in TAU. These outcomes were sustained 6 months after treatment. Standardized relative effect sizes were large for complaints of difficulty initiating sleep, waking from sleep during the night, and for sleep efficiency (percentage of time in bed spent asleep). CBT was associated with moderate to large effect sizes for five of seven QOL outcomes, including significant reduction in daytime fatigue. There was no significant interaction effect between any of these outcomes and baseline demographic, clinical, or sleep characteristics.CONCLUSION: CBT for insomnia may be both clinically effective and feasible to deliver in real world practice.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Cognitive Therapy

KW - Female

KW - Humans

KW - Linear Models

KW - Male

KW - Middle Aged

KW - Neoplasms

KW - Psychometrics

KW - Quality of Life

KW - Sleep Initiation and Maintenance Disorders

KW - Treatment Outcome

U2 - 10.1200/JCO.2007.13.9006

DO - 10.1200/JCO.2007.13.9006

M3 - Article

VL - 26

SP - 4651

EP - 4658

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 28

ER -